Evidence map›Paper›PMID 42852072›Full record

ArticleHemaSphere2026

Response to two comments on "EHA Guidelines on management of chronic lymphocytic leukemia and Richter transformation" by S. Molica and A. Tedeschi: Beyond the binary choice.

Barbara Eichhorst, Paolo Ghia, Francesc Bosch, Ruth Clifford, Michael Gregor, Romain Guieze, Arnon P Kater, Carsten U Niemann, Sarka Pospisilova, Tadeusz Robak and 4 more

Abstract readEditorial
PubMed Full text at PMC Publisher
In one paragraph

Article in HemaSphere, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Barbara EichhorstDepartment I for Internal Medicine Center of Integrated Oncology Aachen, Bonn, Cologne, Dusseldorf, University of Cologne Cologne Germany.ORCID https://orcid.org/0000-0001-9990-6918
Paolo GhiaMedical School Università Vita-Salute San Raffaele Milano Italy.ORCID https://orcid.org/0000-0003-3750-7342
Francesc BoschDepartment of Hematology University Hospital Vall d'Hebron, Vall d'Hebron Institute of Oncology (VHIO) Barcelona Spain.
Ruth CliffordDepartment of Haematology, Cancer Services University Hospital Limerick Limerick Ireland.
Michael GregorDivision of Hematology Luzerner Kantonsspital Luzern Switzerland.
Romain GuiezeUniversity Hospital of Clermont-Ferrand and Université Clermont Auvergne Clermont-Ferrand France.ORCID https://orcid.org/0000-0001-7563-580X
Arnon P KaterDepartment of Hematology Cancer Center Amsterdam, Amsterdam University Medical Centers, Also on Behalf of Hovon Amsterdam The Netherlands.ORCID https://orcid.org/0000-0003-3190-1891
Carsten U NiemannDepartment of Hematology Rigshospitalet, Copenhagen University Hospital Copenhagen Denmark.ORCID https://orcid.org/0000-0001-9880-5242
Sarka PospisilovaCEITEC and Department of Internal Medicine, Hematology and Oncology Faculty of Medicine, Masaryk University and University Hospital Brno Brno Czech Republic.
Tadeusz RobakDepartment of Hematology Medical University of Lodz Lodz Poland.ORCID https://orcid.org/0000-0002-3411-6357
Anna SchuhDepartment of Oncology University of Oxford Oxford United Kingdom.
Kostas StamatopoulosInstitute of Applied Biosciences, Centre for Research and Technology Hellas Thessaloniki Greece.ORCID https://orcid.org/0000-0001-8529-640X
Tamar TadmorHematology Unit Bnai-Zion Medical Center, and the Ruth and Bruce Rappaport Faculty of Medicine, Technion Haifa Israel.ORCID https://orcid.org/0000-0002-3435-8612
Nick YorkLeukaemia Care One Birch Court Worcester United Kingdom.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42852072
PMCPMC13649005

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.